CRIS Current Research Information System

FINELLI, CARLO

FINELLI, CARLO  

Mostra records
Risultati 1 - 20 di 55 (tempo di esecuzione: 0.036 secondi).
Titolo Autore(i) Anno Periodico Editore Tipo File
MTHFR, TS and XRCC1 genetic variants may affect survival in patients with myelodysplastic syndromes treated with supportive care or azacitidine Visani, G; Loscocco, F; Ruzzo, A; Galimberti, S; Graziano, F; Voso, M T; Giacomini, E; Finelli, C...; Ciabatti, E; Fabiani, E; Barulli, S; Volpe, A; Magro, D; Piccaluga, P; Fuligni, F; Vignetti, M; Fazi, P; Piciocchi, A; Gabucci, E; Rocchi, M; Magnani, M; Isidori, A 2018-01-01 PHARMACOGENOMICS JOURNAL - 1.01 Articolo in rivista -
Molecular Characterization of High-Risk MDS Patients Treated with Azacitidine and Lenalidomide: Role of Inositide-Dependent Signalling, Mutations and Microrna Follo, M.Y.; Pellagatti, A.; Armstrong, R.N.; Mongiorgi, S.; Astolfi, A.; Indio, V.; Ratti, S.; C...lissa, C.; Barraco, M.; Parisi, S.; Manzoli, L.; Pession, A.; Cocco, L.; Boultwood, J.; Finelli, C. 2017-01-01 LEUKEMIA RESEARCH - 4.01 Contributo in Atti di convegno -
Clinical Impact of Hypomethylating Agents in the Treatment of Myelodysplastic Syndromes Finelli, Carlo; Follo, Matilde Y; Stanzani, Marta; Parisi, Sarah; Clissa, Cristina; Mongiorgi, Sa...ra; Barraco, Marilena; Cocco, Lucio 2016-01-01 CURRENT PHARMACEUTICAL DESIGN - 1.01 Articolo in rivista -
Epigenetic regulation of nuclear PLCbeta1 and Cyclin D3 during Azacitidine treatment Stefano Ratti, Sara Mongiorgi, Marta Stanzani, Carlo Finelli, Lucio Ildebrando Cocco, Lucia Manzo...li, Anna Maria Billi, Irene Faenza, Giulia Ramazzotti, Roberta Fiume, Matilde Yung Follo 2016-01-01 - - 4.01 Contributo in Atti di convegno -
Inositide-dependent signaling pathways as new therapeutic targets in myelodysplastic syndromes Mongiorgi, Sara; Finelli, Carlo; Yang, Yong Ryoul; Clissa, Cristina; Mccubrey, James A.; Billi, A...nna Maria; Manzoli, Lucia; Suh, Pann-Ghill; Cocco, Lucio; Follo, Matilde Y 2016-01-01 EXPERT OPINION ON THERAPEUTIC TARGETS - 1.01 Articolo in rivista -
An increased expression of PI-PLCβ1 is associated with myeloid differentiation and a longer response to azacitidine in myelodysplastic syndromes Cocco, Lucio; Finelli, Carlo; Mongiorgi, Sara; Clissa, Cristina; Russo, Domenico; Bosi, Costanza;... Quaranta, Marilisa; Malagola, Michele; Parisi, Sarah; Stanzani, Marta; Ramazzotti, Giulia; Mariani, Giulia A.; Billi, Anna Maria; Manzoli, Lucia; Follo, Matilde Y. 2015-01-01 JOURNAL OF LEUKOCYTE BIOLOGY - 1.01 Articolo in rivista -
[Molecular biology in myelodysplastic syndromes and acute myeloid leukemias "smoldering"] Martinelli, Giovanni; Sartor, Chiara; Papayannidis, Cristina; Iacobucci, Ilaria; Paolini, Stefani...a; Clissa, Cristina; Ottaviani, Emanuela; Finelli, Carlo 2014-01-01 RECENTI PROGRESSI IN MEDICINA - 1.01 Articolo in rivista -
DIFFERENTIAL EFFECT OF LENALIDOMIDE ON INDUCTION OF INOSITIDE-DEPENDENT ERYTHROPOIESIS AND CELL CYCLE IN MYELODYSPLASTIC SYNDROMES Follo, My; Mongiorgi, S; Clissa, C; Stanzani, M; Poli, A; Lonetti, A; Cappellini, A; Manzoli, L; ...Cocco L, 1; Finelli, C 2014-01-01 HAEMATOLOGICA - 4.02 Riassunto (Abstract) -
RASGRP1/APTX ratio is a strong biomarker which predicts response to therapy with Tipifarnib plus Bortezomib in elderly patients with Acute Myeloid Leukemia (AML) Cristina Papayannidis, Stefania Paolini, Emanuela Ottaviani, Federica Salmi, Barbara Lama, Antoni...o Curti, Ilaria Iacobucci, Sarah Parisi, Cristina Clissa, Pier Paolo Piccaluga, Daniela Cilloni, Giuseppe Saglio, Anna Candoni, Fortunato Morabito, Carlo Finelli, Nicola Vianelli, Mitch Raponi, Massimo Serra, Michele Baccarani, Giovanni Martinelli 2014-01-01 CANCER RESEARCH - 1.06 Abstract in rivista -
Strategic Role of Nuclear Inositide Signalling in Myelodysplastic Syndromes Therapy Manzoli L; Mongiorgi S; Clissa C; Finelli C; Billi AM; Poli A; Quaranta M; Cocco L; Follo MY 2014-01-01 MINI-REVIEWS IN MEDICINAL CHEMISTRY - 1.01 Articolo in rivista -
AZACITIDINE IN HIGH AND LOW RISK MYELODYSPLASTIC SYNDROMES: RETROSPECTIVE EVALUATION OF 57 PATIENTS TREATED WITH 4 DIFFERENT THERAPEUTIC REGIMENS Clissa C;Finelli C;Follo MY; Stanzani M; Curti A; Paolini S;
Papayannidis C; Mongiorgi S; Parisi ...S; Abbenante MC; Bosi C;
Manzoli L; Martinelli G; Cocco L; Cavo M 		2013-01-01 HAEMATOLOGICA - 4.01 Contributo in Atti di convegno -
CLONAL ACTIVATION OF AKT IN LOW-RISK MDS PATIENTS WITH DEL(5Q) TREATED WITH LENALIDOMIDE Follo MY; Clissa C; Mongiorgi S; Stoyanova M; Paolini S; Quaranta
M; Stanzani M; Martinelli G; Ma...nzoli L; Cocco L; Finelli C 		2013-01-01 HAEMATOLOGICA - 4.01 Contributo in Atti di convegno -
Clonal activation of Akt in low-risk MDS patients with del(5q) treated with lenalidomide M.Y. Follo; S. Mongiorgi; C. Clissa; M. Stoyanova; S. Paolini; M. Quaranta; G. Martinelli; L. Man...zoli; C. Cocco; C. Finelli 2013-01-01 LEUKEMIA RESEARCH - 4.01 Contributo in Atti di convegno -
Clonal Effect Of Lenalidomide On Akt Activation In Low-Risk MDS Patients With Del(5q) Matilde Y Follo; Carlo Finelli; Cristina Clissa; Sara Mongiorgi; Carmen Baldazzi; Marta Stanzani;... Michele Baccarani; Lucio Cocco 2013-01-01 BLOOD - 4.01 Contributo in Atti di convegno -
Long-lasting hematologic response to azacitidine in myelodysplastic syndromes: Multicenter retrospective study of 36 patients C. Finelli; C. Clissa; M.T. Voso; M.A. Aloe Spiriti; M. Breccia; G. Gaidano; M. Crugnola; M.B. Gi...annini; A. Poloni; C. Bosi; V. Naso; M.Y. Follo; G. Martinelli; M. Cavo 2013-01-01 LEUKEMIA RESEARCH ELSEVIER 4.01 Contributo in Atti di convegno -
Nuclear phospholipase C β1 signaling, epigenetics and treatments in MDS Follo MY; Marmiroli S; Faenza I; Fiume R; Ramazzotti G; Martelli AM; Gobbi P; McCubrey JA; Finell...i C; Manzoli FA; Cocco L 2013-01-01 ADVANCES IN BIOLOGICAL REGULATION - 1.01 Articolo in rivista -
PI-PLCBETA1 GENE METHYLATION AND EXPRESSION AS A RELIABLE AND DYNAMIC MARKER OF CLINICAL RESPONSE TO 5-AZACYTIDINE IN PATIENTS WITH LOW-RISK MYELODYSPLASTIC SYNDROMES Follo MY; Malagola M; Filì C; Finelli C; Iacobucci I; Martinelli G;
Cattina F; Clissa C;Candoni A...; Fanin R; Gobbi M; Bocchia M;
Defina M; Spedini P; Skert C; Manzoli L; Cocco L; Russo D 		2013-01-01 HAEMATOLOGICA - 4.01 Contributo in Atti di convegno -
Prospective phase II Study on 5-days azacitidine for treatment of symptomatic and/or erythropoietin unresponsive patients with low/INT-1-risk myelodysplastic syndromes Filì C; Malagola M; Follo MY; Finelli C; Iacobucci I; Martinelli G; Cattina F; Clissa C; Candoni ...A; Fanin R; Gobbi M; Bocchia M; Defina M; Spedini P; Skert C; Manzoli L; Cocco L; Russo D. 2013-01-01 CLINICAL CANCER RESEARCH - 1.01 Articolo in rivista -
Activation of nuclear inositide signalling pathways during erythropoietin therapy in low-risk MDS patients Follo M.Y.; Mongiorgi S.; Clissa C.; Paolini S.; Martinelli G.; Martelli A.M.; Fioravanti G.; Man...zoli L.; Finelli C.; Cocco L. 2012-01-01 LEUKEMIA - 1.01 Articolo in rivista -
Azacitidine in Myelodysplastic Syndromes: Multicenter Retrospective Study of 34 Long-Responder Patients Carlo Finelli; Cristina Clissa; Maria Teresa Voso; Maria Antonietta Aloe Spiriti; Massimo Breccia...; Gianluca Gaidano; Monica Crugnola; Maria Benedetta Giannini; Costanza Bosi; Virginia Naso; Matilde Y Follo; Sara Mongiorgi; Giovanni Martinelli; Lucio Cocco; Michele Baccarani 2012-01-01 BLOOD - 4.02 Riassunto (Abstract) -